SCHEMBL31644797

SCHEMBL31644797

C=CCC[C@@H](C)Oc1nc(C)ccc1SCCC(=O)OC[C@H](CC)CCCC

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ ATM Q13315 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.38
▸ CA2 P00918 1/20 0.38
▸ MAPK1 P28482 3/20 0.36
▸ LMNA P02545 3/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ RECQL P46063 1/20 0.34
▸ PRSS1 P07477 1/20 0.34
▸ PRSS2 P07478 1/20 0.34
▸ PRSS3 P35030 1/20 0.34
▸ PDE1A P54750 1/20 0.32
▸ PDE1B Q01064 1/20 0.32
▸ PDE1C Q14123 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.30
▸ POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31645304 0.90 CYP3A4 (0.42) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL31644838 0.82 CYP3A4 (0.51) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL31644782 0.81 CYP3A4 (0.35) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL31644815 0.74 CYP3A4 (0.53) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL31260325 0.73 TSHR (0.50) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL22980400 0.72 CYP3A4 (0.49) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL16387388 0.72 CYP3A4 (0.51) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL31260413 0.72 TSHR (0.48) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL21111957 0.71 TSHR (0.50) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL21383708 0.71 CYP3A4 (0.49) TSHRCYP3A4TDP1ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025132542-A1 MACROCYCLIC OREXIN AGONISTS IDORSIA PHARMACEUTICALS LTD (CH) 2025-06-26 — — WO disclosed
Send feedback